Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby
BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
thebluntness1d
Cannabis Study Offers Hope for Veterans Battling PTSD
FDA approves groundbreaking Phase 2 trial studying smoked marijuana for veterans with PTSD. Will this research finally ...
Zacks.com on MSN1d
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Bayer BAYRY announced that the FDA has accepted its supplemental new drug application (sNDA) for Nubeqa (darolutamide). The ...
Maurice Ferré-led health tech company wins FDA approval
Insightec received FDA approval for use with Philips MRI scanners. Insightec's Exablate Prime treats essential tremor and ...
medtechdive1d
Medtronic nets FDA nod for smart insulin pen app
The clearance paves the way for the launch of Medtronic’s Smart MDI system, which combines its InPen and Simplera continuous ...
GlobalData on MSN1d
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
The request is based on findings from the Phase III ASTRO study, which achieved the primary endpoint of clinical remission at ...
How potentially harmful additives have infiltrated America’s food
A legal loophole allows companies to add new additives into your food without approval from the Food and Drug Administration.
FDA's historic approval of PTSD study may boost cannabis sector down the road
The roughly $13 million trial is being funded by the Michigan Veteran Marijuana Research Grant Program. MAPS, a nonprofit research group based in San Jose, Calif., that is known for its work to ...
Ohio State licenses cancer drug with 'tremendous potential' invented at the James
An experimental drug starting clinical trials next month at Ohio State University's James Cancer Hospital represents a first ...
Yahoo Finance1d
MDT Stock Gains From FDA Approval for Its InPen App
This latest FDA clearance should pave the way for the launch of the company’s Smart MDI system, which combines the InPen ...
Morningstar1d
While legalizing marijuana is in limbo, FDA clears a PTSD study that could boost cannabis stocks over time
Given the large number of veterans who could use a new treatment for PTSD, a favorable study on cannabis could pave the way for more widespread ... for Psychedelic Studies said this week that the FDA ...
FDA grants accelerated approval to Jazz Pharmaceuticals’ Ziihera
The Food and Drug Administration granted accelerated approval to zanidatamab-hrii, or Ziihera from Jazz Pharmaceuticals (JAZZ), Inc., a ...